Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
≥99.0% Lot SL-2026-117
CJC-1295 5 mg — ≥99.0% analytical research vial
≥99.0%
Analytical Purity
24–48h Dispatch
CH/EU Cold-Chain
SL-2026-117
Active Batch Lot
GH Secretagogues & Growth Factors • In stock — Ready to ship

CJC-1295 (5 mg)

€48 5 mg • EUR
Related Formats: CJC-1295 (5 mg) CJC-1295 (no DAC) (5 mg) — €44

CJC-1295 with DAC incorporates a C-terminal maleimidopropionic acid (MPA) Drug Affinity Complex linker that forms a covalent bioconjugate with serum albumin Cys34, extending terminal half-life to 6–8 days in endocrine models.

Chemical & Registry Specifications
CAS Registry Number 863288-34-0 (with DAC)
Molecular Formula C165H269N47O46
Molecular Weight 3647.28 g/mol
Counterion / Form Acetate lyophilized salt
Sequence / Structural Class Mod GRF(1-29)-Lys(MPA)-NH2 (C-terminal Drug Affinity Complex)
Primary Biological Target / Pathway Pituitary GHRH Receptor + Covalent Serum Albumin (Cys34) Binding
Cold-chain dispatch: CH 1–2d (Free) • EU 2–4d (€12, Free >€150) Shipping & returns
Min. order €220.00 • Payment via SEPA Bank Transfer (EUR) (request IBAN via LiveChat/email) or Crypto (BTC, ETH, USDT, USDC, SOL, XMR).

Scientific Profile & Research Key Points: CJC-1295

CJC-1295 with DAC incorporates a C-terminal maleimidopropionic acid (MPA) Drug Affinity Complex linker that forms a covalent bioconjugate with serum albumin Cys34, extending terminal half-life to 6–8 days in endocrine models.

Verified intact C-terminal MPA linker (+279.3 Da over No-DAC)
Models continuous multi-day GHRH-R stimulation
≥99.0% analytical HPLC purity & moisture <3%
Primary Literature Reference Teichman S.L. et al., J Clin Endocrinol Metab (2006) — Prolonged GH/IGF-1 elevation by CJC-1295 DAC (PMID: 16352683)
View on PubMed ↗

Active Batch Release Specifications (Lot SL-2026-117)

Analytical release verification for current CJC-1295 (5 mg) inventory

Open Full Batch Registry
Batch Lot # Release Date Analytical Method Purity Spec Endotoxin (LAL) Moisture
SL-2026-117 2026-10-28 RP-HPLC (C18, 214nm) + ESI-MS ≥99.0% (Single Peak) <0.5 EU/mg <2.8% (Karl Fischer)

Laboratory Solubilization & Storage Protocol

Recommended Solvent / Handling

Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL)

Temperature & Stability

Store lyophilized at -20°C; refrigerate reconstituted solution at 2°C–8°C and use within 21 days (avoid thiol nucleophiles).

CJC-1295 — Technical Questions & Answers

What is the molar concentration when reconstituting CJC-1295 (5 mg) in 2.0 mL?

Reconstituting the full 5 mg vial of CJC-1295 (MW 3647.28 g/mol) in 2.0 mL of diluent produces a 2.50 mg/mL stock solution — equivalent to approximately 0.69 mM (685 µM) gross molarity before Net Peptide Content (NPC) adjustment.

How does CJC-1295's counterion stoichiometry affect assay mass calculations?

CJC-1295 (CAS 863288-34-0 (with DAC), formula C165H269N47O46) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.

Which analytical methods verify CJC-1295 Lot SL-2026-117 and what pathway does it target?

Lot SL-2026-117 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 3647.28 g/mol. In preclinical literature, CJC-1295 targets Pituitary GHRH Receptor + Covalent Serum Albumin (Cys34) Binding (Teichman S.L. et al., J Clin Endocrinol Metab (2006) — Prolonged GH/IGF-1 elevation by CJC-1295 DAC (PMID: 16352683)).

Research Use Only (RUO): CJC-1295 is supplied strictly for laboratory in-vitro experimentation and analytical investigation by qualified personnel. Not for human or veterinary administration.

Related Scientific Monographs

Peer-reviewed mechanism summaries and analytical protocols

All monographs (44)

Related GH Secretagogues & Growth Factors Compounds

View category →
≥99.0%
ACE-031 1 mg — ≥99.0% Research Vial
ACE-031
1 mg In stock
CAS 1169766-01-1
MW: ~79.0 kDa (homodimer)
€75
≥99.0%
CJC-1295 + Ipamorelin 5mg + 5mg — ≥99.0% Research Vial
CJC-1295 + Ipamorelin
5mg + 5mg In stock
CAS 863288-34-0 / 170851-70-4
MW: 3367.97 g/mol & 711.86 g/mol
€62
≥99.0%
Follistatin 1 mg — ≥99.0% Research Vial
Follistatin
1 mg In stock
CAS 117628-82-7
MW: ~34.8 kDa (non-glycosylated core)
€82

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog